UK markets open in 1 hour 26 minutes
  • NIKKEI 225

    28,509.10
    -591.28 (-2.03%)
     
  • HANG SENG

    28,610.65
    -525.08 (-1.80%)
     
  • CRUDE OIL

    62.61
    +0.17 (+0.27%)
     
  • GOLD FUTURES

    1,783.70
    +5.30 (+0.30%)
     
  • DOW

    33,821.30
    -256.33 (-0.75%)
     
  • BTC-GBP

    39,854.92
    +322.55 (+0.82%)
     
  • CMC Crypto 200

    1,276.00
    +41.58 (+3.37%)
     
  • ^IXIC

    13,786.27
    -128.50 (-0.92%)
     
  • ^FTAS

    3,920.05
    -76.60 (-1.92%)
     

Global Facial Skin Ablative Treatment Market Research Report: (2020 to 2030) - Industry Analysis and Demand Forecast

Research and Markets
·7-min read

Dublin, April 01, 2021 (GLOBE NEWSWIRE) -- The "Facial Skin Ablative Treatment Market Research Report: By Technology, Application, Demography - Global Industry Analysis and Demand Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Drivers such as the booming geriatric population, surging number of aesthetic procedures, growing awareness regarding advanced aesthetic treatments, and increasing technological advancements will facilitate the facial skin ablative treatment market growth at a CAGR of 7.8% during the forecast period (2020-2030). The market was valued at $4,134.6 million in 2019, and it is expected to reach $8,394.3 million by 2030. With the increasing focus on improved appearances, the demand for energy-based aesthetic treatments will amplify in the coming years.

The increasing awareness regarding aesthetic procedures, on account of the rising number of exhibitions, seminars, and conferences aimed at generating awareness among the general public and healthcare professionals about the developments in aesthetic and cosmetic treatments will act as a catalyst for the market growth. For example, EuroMediCom (Informa Group) organized the Aesthetic & Anti-Aging Medicine World Congress (AMWC) in April 2019 in Monte Carlo, Monaco. The conference featured five sessions on anti-aging and aesthetics, with knowledge sharing and discussions by experts and leaders.

The technology segment of the facial skin ablative treatment market is classified into dermal fillers, laser skin resurfacing, radiofrequency (RF) microneedling, and mesotherapy. Among these, the RF microneedling category is projected to register the highest CAGR during the forecast period owing to the increasing adoption of RF microneedling skin-tightening technology for reducing wrinkles and fine lines, especially around the mouth, cheeks, and eyes. It also helps in reducing stretch marks, pores, and acne scars, while minimizing the downtime.

Furthermore, the Asia-Pacific (APAC) facial skin ablative treatment market is expected to display the highest growth rate during the forecast period. This can be ascribed to the growing population, rising investments by treatment product manufacturers, expanding medical tourism industry, and increasing personal disposable income and healthcare expenditure. In addition, with the increasing geriatric population in the region, the appearance consciousness is growing, which is another key market driver for the popularity of such treatments and the devices used for the purpsose.

Thus, the availability of novel technologies and surging awareness regarding aesthetic and cosmetic procedures are expected to give an impetus to the market in the forecast years.

Key Topics Covered:

Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Technology
1.3.2 Market Segmentation by Application
1.3.3 Market Segmentation by Demography
1.3.4 Market Segmentation by Region
1.3.5 Analysis Period
1.3.6 Market Data Reporting Unit
1.4 Key Stakeholders

Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Currency Conversion Rates
2.6 Assumptions for the Study
2.7 Notes & Caveats

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Technology
4.1.1.1 Radiofrequency (RF) microneedling
4.1.1.2 Dermal fillers
4.1.1.3 Laser skin resurfacing
4.1.1.4 Mesotherapy
4.1.2 By Application
4.1.2.1 Wrinkles
4.1.2.2 Aging
4.1.2.3 Acne and other scars
4.1.2.4 Hyperpigmentation
4.1.2.5 Others
4.1.3 By Demography
4.1.3.1 Baby boomers
4.1.3.2 Generation X
4.1.3.3 Generation Y
4.1.3.4 Generation Z
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Rising inclination toward improved appearance
4.2.2 Drivers
4.2.2.1 Increasing awareness through seminars and conferences
4.2.2.2 Surging geriatric population
4.2.2.3 Rising disposable income
4.2.2.4 Growing medical tourism industry
4.2.2.5 Increasing volume of anti-aging cosmetic procedures
4.2.2.6 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Stringent regulatory requirements
4.2.3.2 Risks and side-effects associated with facial skin ablative treatment products
4.2.3.3 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Unmet need for minimally or non-invasive treatments
4.2.4.1 Extensive research leading to technical innovations
4.3 Impact of COVID-19
4.4 Porter's Five Forces Analysis

Chapter 5. Global Market Size and Forecast
5.1 By Technology
5.2 By Application
5.3 By Demography
5.4 By Region

Chapter 6. North America Market Size and Forecast
6.1 By Technology
6.2 By Application
6.3 By Demography
6.4 By Country
6.4.1 U.S. Facial Skin Ablative Treatment Market
6.4.1.1 By technology
6.4.1.2 By application
6.4.1.3 By demography
6.4.2 Canada Facial Skin Ablative Treatment Market
6.4.2.1 By technology
6.4.2.2 By application
6.4.2.3 By demography

Chapter 7. Europe Market Size and Forecast
7.1 By Technology
7.2 By Application
7.3 By Demography
7.4 By Country
7.4.1 Germany Facial Skin Ablative Treatment Market
7.4.1.1 By technology
7.4.1.2 By application
7.4.1.3 By demography
7.4.2 France Facial Skin Ablative Treatment Market
7.4.2.1 By technology
7.4.2.2 By application
7.4.2.3 By demography
7.4.3 U.K. Facial Skin Ablative Treatment Market
7.4.3.1 By technology
7.4.3.2 By application
7.4.3.3 By demography
7.4.4 Italy Facial Skin Ablative Treatment Market
7.4.4.1 By technology
7.4.4.2 By application
7.4.4.3 By demography
7.4.5 Spain Facial Skin Ablative Treatment Market
7.4.5.1 By technology
7.4.5.2 By application
7.4.5.3 By demography

Chapter 8. APAC Market Size and Forecast
8.1 By Technology
8.2 By Application
8.3 By Demography
8.4 By Country
8.4.1 China Facial skin ablative treatment market
8.4.1.1 By technology
8.4.1.2 By application
8.4.1.3 By demography
8.4.2 Japan Facial Skin Ablative Treatment Market
8.4.2.1 By technology
8.4.2.2 By application
8.4.2.3 By demography
8.4.3 India Facial Skin Ablative Treatment Market
8.4.3.1 By technology
8.4.3.2 By application
8.4.3.3 By demography
8.4.4 Australia Facial Skin Ablative Treatment Market
8.4.4.1 By technology
8.4.4.2 By application
8.4.4.3 By demography

Chapter 9. LATAM Market Size and Forecast
9.1 By Technology
9.2 By Application
9.3 By Demography
9.4 By Country
9.4.1 Brazil Facial Skin Ablative Treatment Market
9.4.1.1 By technology
9.4.1.2 By application
9.4.1.3 By demography

Chapter 10. MEA Market Size and Forecast
10.1 By Technology
10.2 By Application
10.3 By Demography
10.4 By Country
10.4.1 Saudi Arabia Facial Skin Ablative Treatment Market
10.4.1.1 By technology
10.4.1.2 By application
10.4.1.3 By demography

Chapter 11. Competitive Landscape
11.1 Strategic Developments of Key Players
11.1.1 Product Launches
11.1.2 Mergers and Acquisitions
11.1.3 Others
11.2 Major Players and Their Offering

Chapter 12. Company Profiles
12.1 Alma Lasers Ltd.
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.2 Lumenis Ltd.
12.3 Syneron Medical Ltd.
12.4 Cutera Inc.
12.5 Sciton Inc.
12.6 EL.EN. S.p.A.
12.7 Laseroptek Co. Ltd.
12.8 Fotona D.o.o.
12.9 Imdad LLC
12.10 Hologic Inc.
12.11 Stryker Corporation
12.12 Crown Laboratories Inc.
12.13 Delasco LLC
12.14 Lutronic Corp.
12.15 INSTITUTE BCN ESTHETICS SL
12.16 Koru Pharmaceuticals Co. Ltd.
12.17 CAREGEN Co. LTD.
12.18 HUGEL Inc.
12.19 Allergan plc
12.20 Galderma SA
12.21 Merz Pharma GmbH & Co. KGaA
12.22 Shenb Co. Ltd.

Chapter 13. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/1i3ovo

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900